Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Clorox Co    CLX

News SummaryMost relevantAll newsSector news 

The Clorox Company : Refutes Silent Spring Institute's Study on Our Consumer Products

03/08/2012 | 09:26am US/Eastern

We have reviewed the findings of Silent Spring's study claiming some U.S. consumer products contain endocrine-disrupting and asthma-related ingredients.

Product safety is a top priority at The Clorox Company and our company guidelines prohibit using endocrine-disrupting ingredients in our products. For those household products containing fragrance ingredients some consider to be asthma related, these ingredients are present at such low concentrations they do not cause irritation or trigger asthma when used as directed.

Our highly skilled scientists evaluate each product's safety, efficacy and regulatory compliance before it makes it to store shelves. Our safety assessments begin with analysis of each of the materials that go into making the product. This includes consideration of short-term and long-term impact from all types of exposures, including incidental or accidental, and routes of exposure such as skin, eye, ingestion and inhalation. Our safety evaluation also includes the assessment of fragrances, dyes, and preservatives, and other proprietary ingredients, in our formulations.

Clorox voluntarily discloses all ingredients for our U.S. and Canadian household cleaning and disinfecting products through our industry-leading initiative, Ingredients Inside (www.IngredientsInside.com), which is available on our corporate web site and mobile platforms.

For more information on our product stewardship guidelines, visit http://www.thecloroxcompany..

React to this article
Latest news on CLOROX CO
11/23DJIcahn May Seek Xerox Board Seats
11/19 CLOROX : DE/ : Submission of Matters to a Vote of Security Holders (form 8-K)
11/19 CLOROX : Earns 100 Percent Score on Human Rights Campaign's 2016 Corporate Equal..
11/17 CLOROX : Declares Regular Quarterly Dividend of 77 Cents Per Share
11/02 CLOROX : DE/ Management's Discussion and Analysis of Financial Condition and Res..
11/02 CLOROX : DE/ : Results of Operations and Financial Condition, Financial Statemen..
11/02 CLOROX : beats Street 1Q forecasts
11/02 CLOROX : Reports 3 Percent Sales Growth and 20 Percent EPS Growth in Q1; Confirm..
10/27 CLOROX : Launches Cold & Flu Pulse: A Socially Predictive Cold & Flu Tracker
10/26 CLOROX : Becomes Signatory to United Nations Global Compact
News chart
Full-screen chart
Income Statement Evolution
More Financials